M. Ishida et al., EFFECTS OF VARIOUS FACTORS ON STEADY-STATE PLASMA-CONCENTRATIONS OF TRAZODONE AND ITS ACTIVE METABOLITE M-CHLOROPHENYLPIPERAZINE, International clinical psychopharmacology, 10(3), 1995, pp. 143-146
Effects of various factors on steady state plasma concentrations of tr
azodone and its active metabolite m-chlorophenylpiperazine (mCPP) were
studied in 43 depressed patients (19 males, 24 females) receiving tra
zodone 150 mg at bedtime for 1-3 weeks, Sixteen cases were smokers, an
d 19 cases were also receiving various benzodiazepines. The means (and
ranges) of plasma concentrations of trazodone and mCPP, and the mCPP/
trazodone ratio were 619 (251-1059) ng/ml, 59 (32-139) ng/ml and 0.100
(0.044-0.219), respectively. Smokers had significantly (p < 0.05) low
er plasma concentrations of trazodone and higher mCPP/trazodone ratios
than non-smokers, Age, sex and co-administration of benzodiazepines d
id not affect any plasma concentrations or the mCPP/trazodone ratio, I
n 11 cases where the dose was increased to 300 mg, neither plasma conc
entration/dose ratios nor the mCPP/trazodone ratio changed significant
ly, The present study thus suggests that: (1) there is a large interin
dividual variation in the metabolism of trazodone; (2) smoking enhance
s the metabolism, but age, sex and co-administration of benzodiazepine
s do not affect it; (3) trazodone and mCPP have linear kinetics.